Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JACI.2003.08.025PMID 14610467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases

  2011cited by this paper
• Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.

  2003cited by this paper
• CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls.

  2003cited by this paper
• CTLA4 is associated with susceptibility to multiple sclerosis.

  2003cited by this paper
• Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis

  2003cited by this paper
• Critical Role of Tumor Necrosis Factor-α and NF-κB in Interferon-γ-induced CD40 Expression in Microglia/Macrophages*

  2002cited by this paper
• CTLA-4–Ig regulates tryptophan catabolism in vivo

  2002cited by this paper
• Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• Suppressor of Cytokine Signaling 1 Inhibits Cytokine Induction of CD40 Expression in Macrophages1

  2002cited by this paper
• Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.

  2002cited by this paper
• Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma -induced CD40 expression in microglia/macrophages.

  2002cited by this paper
• Administration of Agonistic Anti-4-1BB Monoclonal Antibody Leads to the Amelioration of Experimental Autoimmune Encephalomyelitis1

  2002cited by this paper
• Genetic background determines the requirement for B7 costimulation in induction of autoimmunity

  2002cited by this paper
• Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.

  2002cited by this paper
• Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease1

  2002cited by this paper
• 4‐1BB‐LIKE MOLECULE IS EXPRESSED IN ISLET‐INFILTRATING MONONUCLEAR CELLS AND IN THE GRAY MATTER OF THE BRAIN

  2002cited by this paper
• Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

  2002cited by this paper
• Expression and Regulation of the PD‐L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells

  2002cited by this paper
• PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2

  2002cited by this paper
• The B7–CD28 superfamily

  2002cited by this paper
• 4-1BB Promotes the Survival of CD8+ T Lymphocytes by Increasing Expression of Bcl-xL and Bfl-11

  2002cited by this paper
• IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions.

  2002cited by this paper
• No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.

  2002cited by this paper
• CTLA4 dimorphisms and the multiple sclerosis phenotype.

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• Amelioration of Experimental Autoimmune Encephalomyelitis with Anti-OX40 Ligand Monoclonal Antibody: A Critical Role for OX40 Ligand in Migration, But Not Development, of Pathogenic T Cells1

  2001cited by this paper
• PD-L2 is a second ligand for PD-1 and inhibits T cell activation

  2001cited by this paper
• CTLA-4 regulates induction of anergy in vivo.

  2001cited by this paper
• The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function

  2001cited by this paper
• CD28-independent induction of experimental autoimmune encephalomyelitis.

  2001cited by this paper
• T-cell regulation by CD28 and CTLA-4

  2001cited by this paper
• ICOS co-stimulatory receptor is essential for T-cell activation and function

  2001cited by this paper
• The Clinical Course of Experimental Autoimmune Encephalomyelitis and Inflammation Is Controlled by the Expression of Cd40 within the Central Nervous System

  2001cited by this paper
• Critical Involvement of OX40 Ligand Signals in the T Cell Priming Events During Experimental Autoimmune Encephalomyelitis1

  2001cited by this paper
• Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.

  2001cited by this paper
• The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE

  2001cited by this paper
• Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment

  2001cited by this paper
• ICOS is critical for CD40-mediated antibody class switching

  2001cited by this paper
• OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

  2001cited by this paper
• Dendritic cell subsets and costimulation for effector T-cell responses.

  2001cited by this paper
• Increased T cell expression of CD154 (CD40‐ligand) in multiple sclerosis

  2001cited by this paper
• Elevated CD40 Ligand Expressing Blood T‐Cell Levels in Multiple Sclerosis Are Reversed by Interferon‐Beta Treatment

  2000cited by this paper
• Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand

  2000cited by this paper
• Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1

  2000cited by this paper
• Facilitation of β Selection and Modification of Positive Selection in the Thymus of Pd-1–Deficient Mice

  2000cited by this paper
• Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor

  2000cited by this paper
• Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells

  2000cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper
• Pathologic Role and Temporal Appearance of Newly Emerging Autoepitopes in Relapsing Experimental Autoimmune Encephalomyelitis1

  2000cited by this paper
• Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

  2000cited by this paper
• CD137 activation abrogates granulocyte‐macrophage colony‐stimulating factor‐mediated anti‐apoptosis in neutrophils

  2000cited by this paper
• A Critical Role for B7/CD28 Costimulation in Experimental Autoimmune Encephalomyelitis: A Comparative Study Using Costimulatory Molecule-Deficient Mice and Monoclonal Antibody Blockade1

  2000cited by this paper
• Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis.

  2000cited by this paper
• CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS.

  2000cited by this paper
• The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion1

  2000cited by this paper
• The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.

  2000cited by this paper
• Role of Ox40 Signals in Coordinating Cd4 T Cell Selection, Migration, and Cytokine Differentiation in T Helper (Th)1 and Th2 Cells

  2000cited by this paper
• Co‐stimulation of antigen‐specific CD4 T cells by 4‐1BB ligand

  2000cited by this paper
• Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis.

  1999cited by this paper
• Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal.

  1999cited by this paper
• The CTLA-4 gene is associated with multiple sclerosis.

  1999cited by this paper
• Compromised Ox40 Function in Cd28-Deficient Mice Is Linked with Failure to Develop Cxc Chemokine Receptor 5–Positive Cd4 Cells and Germinal Centers

  1999cited by this paper
• T-cell co-stimulation through B7RP-1 and ICOS

  1999cited by this paper
• ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

  1999cited by this paper
• T lymphocyte costimulation mediated by reorganization of membrane microdomains.

  1999cited by this paper
• Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

  1999cited by this paper
• B7-1 or B7-2 Is Required to Produce the Lymphoproliferative Phenotype in Mice Lacking Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4)

  1999cited by this paper
• Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis

  1999cited by this paper
• Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.

  1999cited by this paper
• IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE).

  1999cited by this paper
• Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.

  1999cited by this paper
• Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).

  1999cited by this paper
• EncephalomyelitisDevelopment of Spontaneous Autoimmune CD28 Costimulation Is Crucial for the

  1999cited by this paper
• Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis.

  1999cited by this paper
• Studies in B7-Deficient Mice Reveal a Critical Role for B7 Costimulation in Both Induction and Effector Phases of Experimental Autoimmune Encephalomyelitis

  1999cited by this paper
• Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.

  1999cited by this paper
• B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

  1999cited by this paper
• CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.

  1999cited by this paper
• OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection.

  1999cited by this paper
• A two-step, two-signal model for the primary activation of precursor helper T cells.

  1999cited by this paper
• CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.

  1999cited by this paper
• Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.

  1998cited by this paper
• The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells.

  1998cited by this paper
• Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.

  1998cited by this paper
• The role of B7 co‐stimulation in activation and differentiation ofCD4+and CD8+T cells

  1998cited by this paper
• Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.

  1998cited by this paper
• Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation.

  1998cited by this paper
• Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).

  1998cited by this paper
• CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand

  1998cited by this paper
• Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

  1998cited by this paper
• Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses.

  1998cited by this paper
• Costimulation of CD28- T lymphocytes by 4-1BB ligand.

  1997cited by this paper
• Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4 (cid:49) T cells via CD40 ligand

  1997cited by this paper
• Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis model.

  1997cited by this paper
• Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity.

  1997cited by this paper
• Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.

  1997cited by this paper
• Expression and function of OX40 ligand on human dendritic cells.

  1997cited by this paper
• Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.

  1997cited by this paper
• Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

  1997cited by this paper

• Comparison of the PD-1 expression level in peripheral blood of Multiple Sclerosis and Neuromyelitis Optica patients

  2024cites this paper
• Treated and Untreated Primary Progressive Multiple Sclerosis: Walkthrough Immunological Changes of Monocytes and T Regulatory Cells

  2024cites this paper
• Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

  2024cites this paper
• Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism

  2023influential citation
• Comparison of OX40 expression in patients with multiple sclerosis and neuromyelitis optica as an approach to diagnosis

  2023cites this paper
• Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases

  2023cites this paper
• Expression of CD40 and CD192 in Classical Monocytes in Multiple Sclerosis Patients Assessed with Transcranial Magnetic Stimulation

  2023cites this paper
• Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

  2022cites this paper
• Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).

  2022cites this paper
• Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis

  2022cites this paper
• The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes

  2022cites this paper
• Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis

  2021cites this paper
• Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen‐Specific Therapy for Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• Evaluation of plasma soluble CD137 level in relapsing-remitting multiple sclerosis patients in comparison with healthy controls in Isfahan Province, Iran

  2020cites this paper
• Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis

  2019cites this paper
• GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.

  2019cites this paper
• Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation

  2018cites this paper
• Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.

  2017cites this paper
• Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation

  2017cites this paper
• Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis

  2017cites this paper
• Involvement of Immune Regulation in Multiple Sclerosis

  2017cites this paper
• Th9 cells in the pathogenesis of EAE and multiple sclerosis

  2016cites this paper
• Translational utility of experimental autoimmune encephalomyelitis: recent developments

  2015cites this paper
• Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.

  2015cites this paper
• The effect of single course high dose dexamethasone on CD28/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia

  2015cites this paper
• Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis

  2014cites this paper
• Departamento de Biología Celular, Fisiología e Inmunología

  2013cites this paper
• Characterizing the immunomodulatory effects of the antioxidant TEMPOL in a model of multiple sclerosis

  2013influential citation
• Pathogenesis of Pediatric Multiple Sclerosis

  2012cites this paper
• The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis.

  2012cites this paper
• Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis.

  2011cites this paper
• Antigen presentation in EAE: role of microglia, macrophages and dendritic cells.

  2011cites this paper
• Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis.

  2011cites this paper
• Characterization of human platelet binding of recombinant T cell receptor ligand

  2010cites this paper
• Role of platelets in neuroinflammation: a wide-angle perspective

  2010cites this paper
• UNCOVERING THE GENETIC ARCHITECTURE OF MULTIPLE SCLEROSIS

  2010cites this paper
• Mechanisms of demyelination and axonal damage in a CD8+ T cell-mediated model of spontaneous demyelinating disease

  2010cites this paper
• Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis: Therapeutic Implications

  2009cites this paper
• Nanotubos de carbono não funcionalizados suprimem a encefalomielite experimental autoimune prejudicando a apresentação do neuro-antigeno

  2009influential citation
• Neuroprotective Features Of Hsp90 Inhibitors Exhibiting Anti-Inflammatory Actions: Implications For Multiple Sclerosis

  2008cites this paper
• Analysis of Myelin-Reactive T Lymphocyte Function in Models of Multiple Sclerosis

  2008cites this paper
• Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.

  2008cites this paper
• EXISTING IMMUNOMODULATORY THERAPY AND POTENTIAL NEUROPROTECTIVE ROLES

  2008cites this paper
• Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis.

  2008cites this paper
• The Immunology of Multiple Sclerosis

  2008cites this paper
• B7‐H1 restricts neuroantigen‐specific T cell responses and confines inflammatory CNS damage: Implications for the lesion pathogenesis of multiple sclerosis

  2008cites this paper
• Effects of interferon-β on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-β treatment in patients with multiple sclerosis

  2008cites this paper
• The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis

  2007cites this paper
• Multiple Sclerosis and Demyelinating Diseases

  2007cites this paper
• Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function

  2007cites this paper
• Diff erential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and eff ector function

  2007cites this paper
• PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.

  2007cites this paper
• CD40 Expression by Microglial Cells Is Required for Their Completion of a Two-Step Activation Process during Central Nervous System Autoimmune Inflammation1

  2006cites this paper
• Autoimmune Inflammation Activation Process during Central Nervous Two-StepRequired for Their Completion of a CD 40 Expression by Microglial Cells Is

  2006cites this paper
• Immunology of multiple sclerosis.

  2005cites this paper
• Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.

  2005cites this paper
• Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats.

  2005cites this paper
• Immunology of multiple sclerosis.

  2005cites this paper
• Effects of sex hormones on costimulatory molecule expression in multiple sclerosis.

  2005cites this paper
• Mechanisms of multiple sclerosis

  2005cites this paper
• Efeito da imunoterapia com interferon beta na produção de citocinas pelos leucocitos de pacientes portadores de esclerose multipla

  2004cites this paper
• Novel approaches and cutting edge immunotherapies in multiple sclerosis.

  2004cites this paper
• Primary immune deficiency disease

  2001cites this paper